Paul Edick - Circassia
Oxford, UK, firm Circassia has announced the appointment of Paul Edick to its Board.
Edick has had a number of high serving roles in the pharma industry and is currently CEO of Durata Therapeutic.
Dr Francesco Granata, Circassia’s Chairman, said: “With Circassia’s cat allergy treatment progressing through phase III testing, after achieving truly unprecedented clinical results to date, Paul’s experience will be invaluable as the company builds the commercial capabilities to launch this potentially revolutionary new therapy.”